safety of compounded tirzepatide first-new analyses B12-compounded @EliLillyandCo https://t.co/Dl3jAe9l8h Eli Lilly just issued a

This once-weekly medication, approved for type 2 diabetes and chronic weight management, has a five-day half-life that provides some scheduling flexibility

On receipt, inspect the vial and transfer it promptly to the stated sealed-storage condition

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Weight loss injections such as semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) work by mimicking a hormone that helps curb hunger and increase feelings of fullness after eating

Because vascular supply and endothelial signaling are closely linked with muscle regeneration processes, these pathways are frequently explored in muscle biology models

The absence of a gallbladder changes bile storage and release, potentially affecting medication absorption and digestive tolerance

Nicholls, MBBS, PhD, director of the Monash Victorian Heart Institute and professor of cardiology at Monash University in Melbourne, Australia, and colleagues randomly assigned 13,165 participants with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) to a maximum tolerated dose of 5 mg, 10 mg or 15 mg once-weekly subcutaneous tirzepatide (Mounjaro, Eli Lilly) or 1.5 mg of once-weekly subcutaneous dulaglutide (Trulicity, Eli Lilly) with sham dose escalation